Can someone explain this to me. The FDA has given tentative approval for generic Eliquis to Lupin. I know this is done with a significant lag time to launch, but can’t find anymore info. https://mybs.in/2VsGT6R
This is true. https://www.business-standard.com/article/companies/lupin-receives-approval-from-usfda-for-generic-apixaban-tablets-118121000787_1.html
The makers have fought off the generic version in court and the earliest you will see this is like year 2026.
Should be more worried the cash cow Revlimid starts to go off patent in March of 2022. BMS has nothing to replace that revenue. By the end of 2022 BMS will be a buyout target again.
